top of page
H2C Advises Tower Health on Monetizing Healthcare Real Estate Portfolio During COVID-19 Pandemic



623 Fifth Avenue
29th Floor
New York, NY 10022



3333 Piedmont Road
Suite 725
Atlanta, GA 30305



311 South Wacker Drive
Suite 5425
Chicago, IL 60606


About Tower Health


Tower Health is a strong, regional, integrated healthcare provider/payer system that offers leading-edge, compassionate healthcare and wellness services to a population of 2.5 million people. Together, our six acute care hospitals and other entities provide a full range of medical care — from prevention, screenings and education; to the latest clinical services and surgeries available; to rehabilitation. We also offer wellness programs and public health services that ensure our communities are the healthiest they can be. Tower Health’s caring, highly trained physicians and staff are committed to patient safety and satisfaction.


About Hammond Hanlon Camp LLC


Hammond Hanlon Camp LLC (“H2C”) is an independent strategic advisory and investment banking firm committed to providing superior advice as a trusted advisor to healthcare organizations and related companies throughout the United States.  H2C’s professionals have a long track record of success in healthcare mergers and acquisitions, capital markets, real estate, and restructuring transactions, acting as lead advisors on hundreds of transactions representing billions of dollars in value.  Hammond Hanlon Camp LLC offers securities through its wholly-owned subsidiary H2C Securities Inc., member FINRA/SIPC.  For more information, visit



Kelly T. Duong
Hammond Hanlon Camp LLC


4655 Executive Drive

Suite 280
San Diego, CA 92121


"H2C accomplished execution of the transaction that closed within 100 days of marketing, overcoming some extraordinary challenges, especially given the global pandemic.”


            — Clint Matthews

                 CEO, Tower Health

Please reload

NEW YORK — Sept. 15, 2020Hammond Hanlon Camp LLC (“H2C”), a healthcare-focused investment banking firm, served as the exclusive financial advisor to Tower Health (“Tower” or “the System”) on the monetization of a 23-asset medical office and healthcare real estate portfolio.


The portfolio, located in Southeast Pennsylvania, totals 651,677 square feet and transacted for $203.7 million.


After completing a comprehensive refinancing of its bonds in February 2020 with H2C as financial advisor, Tower sought to improve overall liquidity and strengthen its credit rating by closing the transaction before the end of its fiscal year—less than six months after engagement. “Unlocking the equity trapped in Tower’s illiquid assets is a crucial part of an integrated strategic plan that our firm has been developing with Tower,” says Michael Hammond, Principal, H2C.


The tight timeline was further complicated by the coronavirus outbreak, which caused real estate investment trusts (“REITs”) and debt capital markets in the medical office sector to seize up. Despite those challenges, H2C launched an aggressive marketing campaign to a targeted list of investors with the capacity to fund a transaction of this size and the capability to close less than four months from initial contact. Because of the need for an expedited process, H2C advised Tower to proactively engage third-party consultants related to environmental, property condition, title, survey, and zoning as well as develop key legal documents that were instrumental in facilitating an on-time closing.


The marketing campaign generated a number of competitive letters of intent. H2C then modeled a detailed transaction impact analysis of each offer to the System’s financials that identified the optimal balance between lease term and rent payments for each property. Ultimately, the portfolio was awarded to a real estate private equity firm that could close in all cash, with aggressive timing on due diligence and closing periods.


“The structure of this transaction enabled Tower to retain strategic control over key assets in our healthcare real estate portfolio while obtaining optimal sale terms,” says Clint Matthews, CEO, Tower Health. “H2C accomplished execution of the transaction that closed within 100 days of marketing, overcoming some extraordinary challenges, especially given the global pandemic.”


“This transaction demonstrates the continued strong interest in healthcare real estate investment during the COVID-19 pandemic,” says PJ Camp, Principal, H2C. “We’re pleased to have supported Tower Health in monetizing its healthcare real estate portfolio with highly competitive pricing, an expedited closing, and formation of a long-term relationship with a top-tier investor.” Email PJ.

bottom of page